Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Uncommon Types of Lung Carcinoma With Mixed Histology: Sarcomatoid Carcinoma, Adenosquamous Carcinoma, and Mucoepidermoid Carcinoma.

Borczuk AC.

Arch Pathol Lab Med. 2018 Aug;142(8):914-921. doi: 10.5858/arpa.2017-0584-RA.

PMID:
30040455
2.

Bi-allelic Mutations in Phe-tRNA Synthetase Associated with a Multi-system Pulmonary Disease Support Non-translational Function.

Xu Z, Lo WS, Beck DB, Schuch LA, Oláhová M, Kopajtich R, Chong YE, Alston CL, Seidl E, Zhai L, Lau CF, Timchak D, LeDuc CA, Borczuk AC, Teich AF, Juusola J, Sofeso C, Müller C, Pierre G, Hilliard T, Turnpenny PD, Wagner M, Kappler M, Brasch F, Bouffard JP, Nangle LA, Yang XL, Zhang M, Taylor RW, Prokisch H, Griese M, Chung WK, Schimmel P.

Am J Hum Genet. 2018 Jul 5;103(1):100-114. doi: 10.1016/j.ajhg.2018.06.006.

3.

Keeping Up With Testing Guidelines in Lung Cancer.

Borczuk AC.

Arch Pathol Lab Med. 2018 Jul;142(7):783-784. doi: 10.5858/arpa.2018-0110-ED. No abstract available.

PMID:
29939779
4.

Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle.

Wang G, Biswas AK, Ma W, Kandpal M, Coker C, Grandgenett PM, Hollingsworth MA, Jain R, Tanji K, Lόpez-Pintado S, Borczuk A, Hebert D, Jenkitkasemwong S, Hojyo S, Davuluri RV, Knutson MD, Fukada T, Acharyya S.

Nat Med. 2018 Jun;24(6):770-781. doi: 10.1038/s41591-018-0054-2. Epub 2018 Jun 6.

PMID:
29875463
5.

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

Tsao MS, Kerr KM, Kockx M, Beasley MB, Borczuk AC, Botling J, Bubendorf L, Chirieac L, Chen G, Chou TY, Chung JH, Dacic S, Lantuejoul S, Mino-Kenudson M, Moreira AL, Nicholson AG, Noguchi M, Pelosi G, Poleri C, Russell PA, Sauter J, Thunnissen E, Wistuba I, Yu H, Wynes MW, Pintilie M, Yatabe Y, Hirsch FR.

J Thorac Oncol. 2018 May 22. pii: S1556-0864(18)30626-9. doi: 10.1016/j.jtho.2018.05.013. [Epub ahead of print]

PMID:
29800747
6.

Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.

Cheng H, Borczuk A, Janakiram M, Ren X, Lin J, Assal A, Halmos B, Perez-Soler R, Zang X.

Clin Cancer Res. 2018 Apr 15;24(8):1954-1964. doi: 10.1158/1078-0432.CCR-17-2924. Epub 2018 Jan 26.

PMID:
29374053
7.

Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomes.

Sfeir MM, Schuetz A, Van Besien K, Borczuk AC, Soave R, Jenkins SG, Walsh TJ, Small CB.

J Clin Pathol. 2018 Jul;71(7):626-630. doi: 10.1136/jclinpath-2017-204777. Epub 2018 Jan 24. Review.

PMID:
29367301
8.

Focusing on Preinvasive Neoplasia: A Molecular Frontier at the Pathologist's Fingertips.

Borczuk AC.

Arch Pathol Lab Med. 2017 Dec;141(12):1604-1605. doi: 10.5858/arpa.2017-0259-ED. No abstract available.

PMID:
29189065
9.

Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung.

Nicholson AG, Torkko K, Viola P, Duhig E, Geisinger K, Borczuk AC, Hiroshima K, Tsao MS, Warth A, Lantuejoul S, Russell PA, Thunnissen E, Marchevsky A, Mino-Kenudson M, Beasley MB, Botling J, Dacic S, Yatabe Y, Noguchi M, Travis WD, Kerr K, Hirsch FR, Chirieac LR, Wistuba II, Moreira A, Chung JH, Chou TY, Bubendorf L, Chen G, Pelosi G, Poleri C, Detterbeck FC, Franklin WA.

J Thorac Oncol. 2018 Feb;13(2):205-217. doi: 10.1016/j.jtho.2017.10.019. Epub 2017 Nov 7.

PMID:
29127023
10.

Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases.

Tandon RT, Jimenez-Cortez Y, Taub R, Borczuk AC.

Arch Pathol Lab Med. 2018 Feb;142(2):236-242. doi: 10.5858/arpa.2017-0092-OA. Epub 2017 Oct 19.

PMID:
29048219
11.

MET-GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors.

Smith MA, Licata T, Lakhani A, Garcia MV, Schildhaus HU, Vuaroqueaux V, Halmos B, Borczuk AC, Chen YA, Creelan BC, Boyle TA, Haura EB.

Clin Cancer Res. 2017 Nov 15;23(22):7084-7096. doi: 10.1158/1078-0432.CCR-16-3006. Epub 2017 Aug 29.

PMID:
28855353
12.

Reproducibility for histologic parameters in peritoneal mesothelioma.

Hartman DJ, Borczuk A, Dacic S, Krasinskas A.

Hum Pathol. 2017 Sep;67:54-59. doi: 10.1016/j.humpath.2017.07.005. Epub 2017 Jul 13.

PMID:
28712777
13.

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Thunnissen E, Allen TC, Adam J, Aisner DL, Beasley MB, Borczuk AC, Cagle PT, Capelozzi VL, Cooper W, Hariri LP, Kern I, Lantuejoul S, Miller R, Mino-Kenudson M, Radonic T, Raparia K, Rekhtman N, Roy-Chowdhuri S, Russell P, Schneider F, Sholl LM, Tsao MS, Vivero M, Yatabe Y.

Arch Pathol Lab Med. 2018 Mar;142(3):408-419. doi: 10.5858/arpa.2017-0106-SA. Epub 2017 Jul 7.

PMID:
28686497
14.

Use of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience.

Asmar R, Sonett JR, Singh G, Mansukhani MM, Borczuk AC.

J Thorac Oncol. 2017 Oct;12(10):1524-1535. doi: 10.1016/j.jtho.2017.06.012. Epub 2017 Jun 21.

PMID:
28647671
15.

Genome-wide association study of subclinical interstitial lung disease in MESA.

Manichaikul A, Wang XQ, Sun L, Dupuis J, Borczuk AC, Nguyen JN, Raghu G, Hoffman EA, Onengut-Gumuscu S, Farber EA, Kaufman JD, Rabinowitz D, Stukovsky KDH, Kawut SM, Hunninghake GM, Washko GR, O'Connor GT, Rich SS, Barr RG, Lederer DJ.

Respir Res. 2017 May 18;18(1):97. doi: 10.1186/s12931-017-0581-2.

16.

Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.

Sangodkar J, Perl A, Tohme R, Kiselar J, Kastrinsky DB, Zaware N, Izadmehr S, Mazhar S, Wiredja DD, O'Connor CM, Hoon D, Dhawan NS, Schlatzer D, Yao S, Leonard D, Borczuk AC, Gokulrangan G, Wang L, Svenson E, Farrington CC, Yuan E, Avelar RA, Stachnik A, Smith B, Gidwani V, Giannini HM, McQuaid D, McClinch K, Wang Z, Levine AC, Sears RC, Chen EY, Duan Q, Datt M, Haider S, Ma'ayan A, DiFeo A, Sharma N, Galsky MD, Brautigan DL, Ioannou YA, Xu W, Chance MR, Ohlmeyer M, Narla G.

J Clin Invest. 2017 Jun 1;127(6):2081-2090. doi: 10.1172/JCI89548. Epub 2017 May 15.

17.

Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.

Manichaikul A, Sun L, Borczuk AC, Onengut-Gumuscu S, Farber EA, Mathai SK, Zhang W, Raghu G, Kaufman JD, Hinckley-Stukovsky KD, Kawut SM, Jelic S, Liu W, Fingerlin TE, Schwartz DA, Sell JL, Rich SS, Barr RG, Lederer DJ.

Ann Am Thorac Soc. 2017 May;14(5):628-635. doi: 10.1513/AnnalsATS.201606-485OC.

18.

The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.

Thunnissen E, Borczuk AC, Flieder DB, Witte B, Beasley MB, Chung JH, Dacic S, Lantuejoul S, Russell PA, den Bakker M, Botling J, Brambilla E, de Cuba E, Geisinger KR, Hiroshima K, Marchevsky AM, Minami Y, Moreira A, Nicholson AG, Yoshida A, Tsao MS, Warth A, Duhig E, Chen G, Matsuno Y, Travis WD, Butnor K, Cooper W, Mino-Kenudson M, Motoi N, Poleri C, Pelosi G, Kerr K, Aisner SC, Ishikawa Y, Buettner RH, Keino N, Yatabe Y, Noguchi M.

J Thorac Oncol. 2017 Feb;12(2):334-346. doi: 10.1016/j.jtho.2016.12.004. Epub 2016 Dec 18.

19.

Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma.

Borczuk AC.

Eur Respir Rev. 2016 Dec;25(142):364-371. doi: 10.1183/16000617.0089-2016. Review.

20.

Challenges of Frozen Section in Thoracic Pathology: Lepidic Lesions, Limited Resections, and Margins.

Borczuk AC.

Arch Pathol Lab Med. 2017 Jul;141(7):932-939. doi: 10.5858/arpa.2016-0415-RA. Epub 2016 Oct 20. Review.

PMID:
27763791
21.

Pulmonary Kirsten Rat Sarcoma Virus Mutation Positive Mucinous Adenocarcinoma Arising in a Congenital Pulmonary Airway Malformation, Mixed Type 1 and 2.

Singh G, Coffey A, Neely R, Lambert D, Sonett J, Borczuk AC, Gorenstein L.

Ann Thorac Surg. 2016 Oct;102(4):e335-7. doi: 10.1016/j.athoracsur.2016.01.104.

PMID:
27645976
22.

HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.

Cheng H, Janakiram M, Borczuk A, Lin J, Qiu W, Liu H, Chinai JM, Halmos B, Perez-Soler R, Zang X.

Clin Cancer Res. 2017 Feb 1;23(3):825-832. doi: 10.1158/1078-0432.CCR-15-3071. Epub 2016 Aug 23.

23.

Over- and Underdiagnosis in Lung Cancer: Searching for a "Solid" Diagnosis.

Borczuk AC.

Radiology. 2016 Sep;280(3):655-8. doi: 10.1148/radiol.2016160791. No abstract available.

PMID:
27533289
24.

Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.

Yong KJ, Basseres DS, Welner RS, Zhang WC, Yang H, Yan B, Alberich-Jorda M, Zhang J, de Figueiredo-Pontes LL, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon YC, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E.

Sci Transl Med. 2016 Aug 3;8(350):350ra104. doi: 10.1126/scitranslmed.aad6066.

PMID:
27488898
25.

An analysis of the relationship between metastases and cachexia in lung cancer patients.

Shiono M, Huang K, Downey RJ, Consul N, Villanueva N, Beck K, Fenn K, Dietz D, Yamaguchi T, Kato S, Divgi C, Kalinsky K, Wei Y, Zhang Y, Borczuk AC, Inoue A, Halmos B, Acharyya S.

Cancer Med. 2016 Sep;5(9):2641-8. doi: 10.1002/cam4.841. Epub 2016 Aug 3.

26.

Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society.

Raparia K, Aisner DL, Allen TC, Beasley MB, Borczuk A, Cagle PT, Capelozzi V, Dacic S, Hariri LP, Kerr KM, Lantuejoul S, Mino-Kenudson M, Rekhtman N, Roden AC, Roy-Chowdhuri S, Sholl L, Smith ML, Thunnissen E, Tsao MS, Yatabe Y.

Arch Pathol Lab Med. 2016 Jul 21. [Epub ahead of print]

PMID:
27441784
27.

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.

Roy-Chowdhuri S, Aisner DL, Allen TC, Beasley MB, Borczuk A, Cagle PT, Capelozzi V, Dacic S, da Cunha Santos G, Hariri LP, Kerr KM, Lantuejoul S, Mino-Kenudson M, Moreira A, Raparia K, Rekhtman N, Sholl L, Thunnissen E, Tsao MS, Vivero M, Yatabe Y.

Arch Pathol Lab Med. 2016 Apr 15. [Epub ahead of print]

PMID:
27081878
28.

Has MET met its match?

Borczuk A, Paucar D, Halmos B.

Ann Transl Med. 2016 Mar;4(5):97. doi: 10.21037/atm.2016.01.15. No abstract available.

29.

Cryobiopsy in the Diagnosis of Interstitial Lung Disease. A Step Forward or Back?

Patel NM, Borczuk AC, Lederer DJ.

Am J Respir Crit Care Med. 2016 Apr 1;193(7):707-9. doi: 10.1164/rccm.201511-2313ED. No abstract available.

PMID:
27035778
30.

Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Churg A, Attanoos R, Borczuk AC, Chirieac LR, Galateau-Sallé F, Gibbs A, Henderson D, Roggli V, Rusch V, Judge MJ, Srigley JR.

Arch Pathol Lab Med. 2016 Oct;140(10):1104-10. doi: 10.5858/arpa.2016-0073-OA. Epub 2016 Mar 31.

31.

Recent advances in the management of pulmonary sarcomatoid carcinoma.

Shum E, Stuart M, Borczuk A, Wang F, Cheng H, Halmos B.

Expert Rev Respir Med. 2016 Mar 10:1-10. [Epub ahead of print]

PMID:
26962707
32.

Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.

Borczuk AC, Pei J, Taub RN, Levy B, Nahum O, Chen J, Chen K, Testa JR.

Cancer Biol Ther. 2016;17(3):328-35. doi: 10.1080/15384047.2016.1145850. Epub 2016 Feb 6.

33.

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.

Sholl LM, Aisner DL, Allen TC, Beasley MB, Borczuk AC, Cagle PT, Capelozzi V, Dacic S, Hariri L, Kerr KM, Lantuejoul S, Mino-Kenudson M, Raparia K, Rekhtman N, Roy-Chowdhuri S, Thunnissen E, Tsao MS, Yatabe Y; Members of Pulmonary Pathology Society.

Arch Pathol Lab Med. 2016 Apr;140(4):341-4. doi: 10.5858/arpa.2015-0506-SA. Epub 2016 Jan 18.

PMID:
26780537
34.

PD-L1 and Lung Cancer: The Era of Precision-ish Medicine?

Borczuk AC, Allen TC.

Arch Pathol Lab Med. 2016 Apr;140(4):351-4. doi: 10.5858/arpa.2015-0509-SA. Epub 2016 Jan 12.

PMID:
26756646
35.

Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells.

Cheng H, Zhang Z, Rodriguez-Barrueco R, Borczuk A, Liu H, Yu J, Silva JM, Cheng SK, Perez-Soler R, Halmos B.

Oncotarget. 2016 May 17;7(20):28976-88. doi: 10.18632/oncotarget.6721.

36.

Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma.

Krasinskas AM, Borczuk AC, Hartman DJ, Chabot JA, Taub RN, Mogal A, Pingpank J, Bartlett D, Dacic S.

Histopathology. 2016 Apr;68(5):729-37. doi: 10.1111/his.12807. Epub 2015 Oct 16.

PMID:
26272336
37.

Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations.

Liu X, Jia Y, Stoopler MB, Shen Y, Cheng H, Chen J, Mansukhani M, Koul S, Halmos B, Borczuk AC.

J Clin Oncol. 2016 Mar 10;34(8):794-802. doi: 10.1200/JCO.2015.62.0674. Epub 2015 Jul 27.

PMID:
26215952
38.

PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling.

Wang X, Li G, Koul S, Ohki R, Maurer M, Borczuk A, Halmos B.

Oncotarget. 2015 Apr 9;9(38):24914-24926. doi: 10.18632/oncotarget.3674. eCollection 2018 May 18.

39.

Genomic alterations in pulmonary adenocarcinoma in situ in an adolescent patient.

Salomao M, Levy B, Nahum O, Chen J, Mansukhani M, Borczuk AC.

Arch Pathol Lab Med. 2014 Apr;138(4):559-63. doi: 10.5858/arpa.2012-0741-CR.

PMID:
24678688
40.

Well-differentiated papillary mesothelioma with invasive foci.

Churg A, Allen T, Borczuk AC, Cagle PT, Galateau-Sallé F, Hwang H, Murer B, Murty VV, Ordonez N, Tazelaar HD, Wick M.

Am J Surg Pathol. 2014 Jul;38(7):990-8. doi: 10.1097/PAS.0000000000000200.

PMID:
24618613
41.

Epidermal growth factor receptor mutations in lung adenocarcinoma.

Siegelin MD, Borczuk AC.

Lab Invest. 2014 Feb;94(2):129-37. doi: 10.1038/labinvest.2013.147. Epub 2013 Dec 30. Review.

42.

EIF2AK4 mutations in pulmonary capillary hemangiomatosis.

Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG.

Chest. 2014 Feb;145(2):231-236. doi: 10.1378/chest.13-2366.

43.

Comparative anatomy of chromosomal domains with imprinted and non-imprinted allele-specific DNA methylation.

Paliwal A, Temkin AM, Kerkel K, Yale A, Yotova I, Drost N, Lax S, Nhan-Chang CL, Powell C, Borczuk A, Aviv A, Wapner R, Chen X, Nagy PL, Schork N, Do C, Torkamani A, Tycko B.

PLoS Genet. 2013 Aug;9(8):e1003622. doi: 10.1371/journal.pgen.1003622. Epub 2013 Aug 29.

44.

A novel channelopathy in pulmonary arterial hypertension.

Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouët DA, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS, Chung WK.

N Engl J Med. 2013 Jul 25;369(4):351-361. doi: 10.1056/NEJMoa1211097.

45.

Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis.

Patel NM, Kawut SM, Jelic S, Arcasoy SM, Lederer DJ, Borczuk AC.

Eur Respir J. 2013 Jun;41(6):1324-30. doi: 10.1183/09031936.00084112.

46.

Thoracoscopic lobectomy for type I pleuropulmonary blastoma in an infant.

Fingeret A, Garcia A, Borczuk AC, Rothenberg SS, Aspelund G.

Pediatr Surg Int. 2014 Feb;30(2):239-42. doi: 10.1007/s00383-013-3310-z. Epub 2013 Apr 16.

PMID:
23588846
47.

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.

Cheng H, Zhang Z, Borczuk A, Powell CA, Balajee AS, Lieberman HB, Halmos B.

Carcinogenesis. 2013 Apr;34(4):739-49. doi: 10.1093/carcin/bgs393. Epub 2012 Dec 28.

48.

Neoplastic and nonneoplastic benign mass lesions of the lung.

Borczuk AC.

Arch Pathol Lab Med. 2012 Oct;136(10):1227-33.

PMID:
23020728
49.

Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung.

Shu C, Cheng H, Wang A, Mansukhani MM, Powell CA, Halmos B, Borczuk AC.

Mod Pathol. 2013 Feb;26(2):239-46. doi: 10.1038/modpathol.2012.158. Epub 2012 Sep 21.

50.

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M; International Mesothelioma Interest Group.

Arch Pathol Lab Med. 2013 May;137(5):647-67. doi: 10.5858/arpa.2012-0214-OA. Epub 2012 Aug 28.

PMID:
22929121

Supplemental Content

Loading ...
Support Center